Antibacterial Drug Discovery to Combat MDR

Antibacterial drug discovery: perspective insights.- Section A: The Challenge of Antibiotic Resistance and Tolerance.- Problematic Groups of Multidrug Resistant Bacteria and their Resistance Mechanisms.- Emergence and spread of multi-drug resistance in ocular bacterial pathogens: A current update.- Antibiotic resistance in Campylobacter jejuni: mechanism, status and public health significance.- Mechanisms of biofilm development, antibiotic resistance & tolerance and their role in persistent infections.- Developing in vivo infection models with MDR pathogens for evaluating compound efficacy.- Section B. New antibiotic drug discovery approaches and progress.- Endophytes: a hidden treasure of novel antimicrobial metabolites.- Alternative therapies to antibiotics to combat drug-resistant bacterial pathogens.- In silico molecular modeling: key technologies in the drug discovery process to combat multidrug resistance.- Computationalapproaches for antibacterial drug discovery.- Efflux pump inhibitors and their role in the reversal of drug resistance.- Medicinal plants as a reservoir of new structures for anti-infective compounds.- Essential oils: Potential application in disease management.- Exploration of soil resistome through a metagenomic approach.- Actinomycetes as a continued source of new antibacterial leads.- Are Ancient Remedies the New Answer to Fighting Infections?.- Section C. Alternative antibiotic resistance treatment strategies.- Pre and probiotics: Using functional foods in the fight against microbial resistance to antibiotics.- Combination of drugs: an effective approach for enhancing the efficacy of antibiotics to combat drug resistance.- Targeted delivery of antibiotics using microparticles to combat multi-drug-resistant tuberculosis.- Practical applications of bacteriophage therapy: biofilms to bedside.- Inhibition of Quorumsensing; prospects in disease control.- Approaches for disrupting tissue-associated biofilms.- Nanomedicine and nanoemulsion in increasing the availability of antibiotics.- Nanoparticles as new emerging antibacterials: potential and limitation.- Nanomaterials as a novel class of anti-infective agents that attenuate bacterial quorum sensing.- Nanoparticle-based drug delivery systems: promising approaches against bacterial infections.- Green synthesis of metal nanoparticles: characterization and their antibacterial efficacy